After each Iowa Board of Pharmacy meeting, the Board and Iowa Pharmacy Association staff discuss WHAT actions were taken by the Board, WHY it took those actions, and HOW practice in Iowa is affected. For information about obtaining CPE credit, visit www.iarx.org/bop_podcast.
Episode #42: January 2023 – IPA Legislative Priorities & Iowa PMP
Following the January 10 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss IPA’s 2023 Legislative Priorities, the Board’s rulemaking related to the Iowa Prescription Monitoring Program (PMP), and more.
Special Edition: December 2022 – Iowa Insurance Division PBM Rules
On December 5, IPA’s Director of Public Affairs, Seth Brown, and Senior Policy Advisor, Brett Barker, recorded a special podcast episode on the Iowa Insurance Division’s release of the PBM rules following the passage of the PBM bill last session. No CE available.
Episode #41: October 2022 – USP Compounding Standards & Delegation of Technical Functions
Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.
Episode #40: August 2022 – Rulemaking Process, Compounding & IMP3 Program
Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.
Episode #39: June 2022 – Updated Security Rules & Statewide Protocol Changes
Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.
Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes
Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.